Improved access to information is necessary to ensure achievement of the potential benefits of medicines in resource-limited countries. The scaling up of treatment and prevention programs involving medicines in resource-limited regions with high disease burdens requires proper and urgent attention to the development and use of information technologies. Areas of need for medicines management systems informatics include prescribing, dispensing, pharmaceutical care, administration, patient monitoring, education and training, supply chain management, and monitoring and evaluation of program performance. Such information systems should strive to collect and manage data that are standardized, compiled, and made easily accessible for use by key stakeholders, including ministries of health, drug regulators, the pharmaceutical industry, public health programs, academic researchers, donor organizations, the health care delivery sector, and ultimately the public and patients. A framework is described for medicines management systems informatics in resource-limited settings.
Introduction
Medicines are an essential component of health care systems in developing countries, accounting for one-third or more of a government's health care budget. It is common for 20-50% of the recurrent government health budget in developing countries to be used to procure drugs. 1 The potential for medicines, including both drugs and vaccines, to improve the health of those in developing countries is widely acknowledged. For example, medicines are among the most important health interventions, their prominence illustrated by their rating by the Disease Control Priorities Project as some of the "best buys" in health, e.g., used to vaccinate children; prevent and treat childhood pneumonia, diarrhea, and malaria; attack the spread of HIV, including providing antiretroviral medications; and treat tuberculosis patients. 2 With the proclamation of the United Nations (UN) Millennium Development goals and the implementation of multinational programs, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, both public and private donors to developing countries are making a new, concerted effort to improve access to medicines.
Yet greater access alone will not necessarily ensure achievement of the Millennium Development or other health-systems goals. Preventing and treating diseases with medicines in developing countries depends on many factors, beginning with drug discovery and development for market introduction. Following an extended period of limited interest in developing medicines for neglected diseases, drug developers are investing in scientific and technological advances and new tools for use in HIV/AIDS, tuberculosis, malaria, and other neglected diseases -often stimulated through new partnerships with donors. Today's pipeline of life-saving medicines and other health products, such as the artemisinin combination therapies (ACTs) for malaria, are beginning to reach the market. However, even the introduction of new medicines alone does not guarantee their appropriate uptake, distribution, and appropriate use.
What we need is adequate data and information about medicines, their use, impact, and management to achieve the goal of improved access to quality, efficacious medicines at affordable cost and ensure their safe and rational use. For purposes of this paper, the term Pharmaceutical Systems Informatics is used to Figure 1 . Elements of Pharmaceutical Management 3 encompass aspects of understanding and promoting the effective organization, analysis, management, and use of information in the pharmaceutical sector. This includes the basic functions of the pharmaceutical management framework, i.e., selection, procurement, distribution and use ( Figure 1 ). Pharmaceutical Systems Informatics represents an intersection of data, science, and technology. Without efforts to ensure that public health decision-makers have accurate and timely pharmaceutical management information, there is a risk that significant resources could be wasted, poor quality products could cause harm, and suboptimal use of medicines could adversely affect patient outcomes.
What Are the Needs for Pharmaceutical Systems Informatics in Developing Countries?
Like other parts of the world, developing countries need continuous availability of essential drugs and the safe, timely distribution of qualityassured medications to persons who need them. Stakeholders at every level need information to make decisions that affect the overall functioning of medication systems. For example, a good pharmaceutical management information system should alert staff to problems and trigger critical actions from multiple levels -whether it is related to the supply chain or patient use of medications. Figure 1 summarizes key information users and some of their most important information needs for each level of the system. 3 Major areas of need for medication systems informatics are as follows:
• Pharmacovigilance is the science and activities relating to the detection, evaluation, understanding and prevention of adverse reactions to medicines or any other medicine-related problems. It is critical for evaluating and characterizing a medicine's riskbenefit profile. 5 Also referred to as postmarketing drug surveillance and phase IV studies, pharmacovigilance is important to assess the use and safety of marketed medicines, particularly for detecting rare or unexpected, but serious adverse reactions; chronic toxicity; effects in understudied populations, such as children and pregnant women; and determining interactions with other products and diseases. Increasingly, pharmacovigilance is viewed as an integral component of post marketing assessment that can greatly improve our understanding of a drug's risk-benefit profile over a medicine's lifecycle ( Figure 2 ). Pharmacovigilance is dependent upon data captured through active and passive surveillance systems. In 2002 Ghana adopted the new antimalarial drug policy based on ACTs and for the choice of drugs, the country selected artesunate + amodiaquine. 6 In the last quarter of 2005, there were reports of serious adverse reactions in patients treated with some brands of this combination, leading to the withdrawal of these brands by Ghana's Ministry of Health.
Effective information systems in developing countries need to play an increasing role in supporting and monitoring access to medicines programs as they scale up from thousands to hundreds of thousands or even millions of patients. The scaling up of treatment programs in regions with high disease burdens and comorbidity offers a unique opportunity to test and establish a framework for systematically capturing, evaluating and using pharmacovigilance information secured from these challenging settings.
Challenges to Medicines Management Systems Informatics in Developing Countries
Resource-limited countries face numerous challenges with the management of pharmaceutical systems, including monitoring and improving the safe use of pharmaceuticals. 7, 8 These challenges relate to the absence of sufficient qualified personnel, overburdened health care systems, poor medicine control/legislation, informal medicine markets where counterfeit and substandard pharmaceuticals are often sold, poor record keeping, poor storage conditions and significant resource constraints. In the area of pharmacovigilance, most resource-limited countries have little infrastructure and few resources, and few have formal systems for routine collection and analysis of data. In the case of pharmacovigilance, there are only eight countries in sub-Saharan Africa with national pharmacovigilance centers that are full members of the WHO program for International Drug Monitoring in Uppsala (namely Ghana, Mozambique, South Africa, Zimbabwe, Tanzania, Nigeria, Uganda, Namibia), seven centers in Central and South America and six centers in resource-poor Asian countries. These centers are staffed by only one or two qualified persons. 9 The challenges are illustrated by considering just a few of the characteristics of some of the most common conditions encountered in Africa and how they are treated. Malaria treatment usually requires repeated doses for treatment of multiple fever episodes-including some doses given without malaria diagnosis (i.e., presumptive treatment). The treatment of HIV and AIDS is considered to be chronic, managed long-term with medications. For antiretroviral therapy (ART) in particular, there are concerns that adverse events may contribute to poor medication adherence, leading to toxicities, changes in regimens, and treatment interruptions that have implications for drug resistance as well as potential for the spread of HIV. Tuberculosis treatment usually lasts many months, increasing the opportunity for cumulative drug exposure and greater opportunity for drug side effects. If patients have concomitant illnesses, this can lead to an increased potential for cumulative toxicity and adverse events due to drug interactions.
In many rural settings neither pharmacies nor pharmacists are used to dispense pharmaceuticals. The sale of drugs in retail stores and over the counter by untrained drug sellers presents a policy dilemma for public health officials who want to ensure access to treatment but at the same time are concerned about the higher likelihood of misuse and inappropriate dosing, which may lead to wastage of valuable drugs such as ACTs and drug resistance. 10 Nongovernmental organizations (NGOs) play an important role in the financing and provision of health care, including pharmaceutical supply services. A study of faithbased drug supply organizations (DSOs) found that the proportion of the population served by 15 faith-based DSOs in 10 countries ranged from 25% to 60%, with an average of 43%. 11 The scaling up of treatment programs in regions with high disease burdens and co-morbidity offers a unique opportunity and obligation to establish a framework for systematically capturing, evaluating and reacting to pharmacovigilance information secured from these challenging settings for the prevention of adverse reactions to medicines or other medicine-related problems.
Key Considerations for Pharmaceutical Systems Informatics in Developing Countries
Information systems should strive to collect and manage data that are standardized, compiled, and made easily accessible for use by key stakeholders. The Institute of Medicine report, Scaling Up Treatment for the Global AIDS Pandemic, describes two main components for information systems. 12 The first is information management, which encompasses data collection and analysis and the second is information technology, which includes telecommunications networks, bandwidth, and service reliability. Within these two components are the areas of data source and data collection; data exchange, interoperability, and data standards; data communications; and data storage and analysis. Here are some key considerations for several of these areas.
Data Sources and Data Collection
The pharmaceutical systems in developing countries use many sources of information, forms and other documents in large quantities and, oftentimes, with variable quality. At the health care facility level, transactions may include inventory tracking, reordering, and billing -each of which is performed with variable levels of automation. The dispensing of medicines to patients may or may not be recorded in a personbased, automated format. The emergence of mobile phones as a widespread and relatively cheap means of communication presents an opportunity to explore the use of this technology in pharmacovigilance. Cell phone usage in Africa is growing almost twice as fast as any other region in the world and jumped from 63 million users in 2004 to 152 million by the end of 2006. 13 Around 66% of Africa's population is now reached by a mobile phone signal, up from 62% in 2007 and some African countries, such as Egypt, Kenya, Rwanda and Uganda, already have coverage rates well above 90%.
14 While only a small proportion of individuals have their own cell phone, most urban and rural areas have mobile phone services on a per-call basis at a modest cost (in Uganda it is about 0.25 USD. Cell phone technology has been used previously to monitor drug safety in Peru and in the United Kingdom. In Peru, Curioso et. al developed an application for cell phones in Spanish, called Cell-PREVEN, based on a system from Voxiva Inc which used cell phones to enter data collected by interviewers monitoring the safety of metronidazole use among sex workers. 15 
Data Exchange, Interoperability, and Standards
These concepts pertain to the need to share information. In order to share health data, the same vocabularies and the same ways of transmitting that information need to be adopted. Sharing information within and between organizations establishes interoperability.
Figure 3. Building a Data Management Information System for MDR-T Surveillance in Brazil 3
Interoperability can be achieved, in part, through standards and common vocabularies.
Case Examples of Applications

Zambia Electronic Perinatal Record System (ZEPRS)
The Zambian Electronic Perinatal Record System (ZEPRS) is a Web-based electronic medical records and referral system designed to improve perinatal care in Lusaka and prevent mother-tochild transmission of HIV/AIDS. 16 Features of ZEPRS include the patient Smart Card or electronic medical records system for 24 networked clinics, UTH, the Lusaka District Health Management Team, and the Ministry of Health over the ZEPRS high-speed wireless network. ZEPRS has been developed using open source software and can operate in networked or stand-alone applications. ZEPRS core architecture permits the software to be adapted to other environments and applications. The technology allows careful monitoring of ARV drug use and resistance, helping to keep more people from having to switch from first-to second-line drugs. As of October 2006, more than 60,000 people in Zambia had received EMRs, and the number of Smart Cards distributed and sites set up with the Continuity of Care Patient Tracking System (CCPTS) is increasing. EMRs have also been used elsewhere for documenting care, monitoring drug adherence and response to therapy, and providing data for quality improvement and research.
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Building a Data Management Information System for MDR-TB Surveillance in Brazil
In Brazil, the Hélio Fraga National TB Reference Center, the National TB Program, and the Rational Pharmaceutical Management Plus Program developed a new data management information system as part of a larger effort to decentralize surveillance of multidrug-resistant tuberculosis (MDR TB) to the states. The pharmaceutical management information system (PMIS) tracks the treatment of MDR-TB patients including diagnosis, case management, pharmaceutical provision and distribution, and second-line medicines. The process of creating the PMIS included a stakeholder working group with representatives from decentralized sites that developed and field-tested standardized procedures, defined indicators, and implemented epidemiological and operational reporting. The information system is Internet-based, so all tools and reports are available online, making information available to users at all levels of the system (see figure below) . The MDR-TB surveillance PMIS system was designed to integrate into existing governmental health surveillance systems. The Internet-based 
Feedback on MIS indicators
Monitoring and technical supervision 6 components of the PMIS include: case notification data sheet; quarterly follow-up data sheet; follow-up data sheet after treatment success; request for MDR-TB medicines; quarterly report on stock turnover for MDR-TB medicines; customized reports; and a data extraction tool (Figure 3 ). The daily administration of several different antiretroviral medicines as part of antiretroviral therapy (ART) requires that each patient is monitored for health status, that results of laboratory tests are tracked and communicated to doctors, and that pharmaceutical supplies are reliably available at each treatment site. Zanmi Lasante, a nongovernmental organization that operated a successful ART site in Haiti's central plateau, was funded to scale up its program to five additional sites. In rural Haiti, where doctors are few, roads are almost nonexistent, and electricity is spotty, creating and maintaining such an information system among disparate sites would be challenging. On the basis of its experience, Zanmi Lasante decided that the cheapest and most flexible communication strategy would be to establish a small satellite connection to the Internet in each of the five new sites. Instead of placing servers in each clinic, one shared server could guarantee a secure environment with stable power and a reliable data backup system. Using Web-based electronic records allows data collection and review from the remote sites, and with one server, the most recent data are accessible to all. The Webbased electronic medical record system in Haiti is built with standard, open-source software. Clinic staff members enter all clinical and medication data using a standardized Web based patient form. To facilitate data entry, the form has validated clinical tools such as an electronic checklist of patient management items, including requests for laboratory tests, details of treatment regimens, and lists of standard ART medicines. Doctors can check the medicines, doses, and administration schedules. As the medicines are entered into the form, they are cross-checked to the patient record for allergies, inappropriate doses, and incompatible medicine combinations. The system displays real-time, onsite warnings about problems-for example, if zidovudine and stavudine are prescribed together. When the form is completed, the user can print out an order for the pharmacy. As new patient information (for example, laboratory results) is added that indicates additional treatment, e-mails are automatically sent to all clinicians with links to the medical records of patients who require follow-up. Staff members also enter warehouse stock data into Web forms, and those figures are analyzed and monitored against expected use patterns from the treatment regimens in the system.
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A Framework for Meeting the Challenges Through Medicines Management Informatics Systems
Effective medicines management informatics systems should be able to plan, implement, organize, and implement the large volumes of data generated by pharmaceutical management operations. Data would then be processed into information for use in planning activities, estimating demand, allocating resources, and monitoring and evaluating pharmaceutical management operations, use, safety, and effectiveness. Another important function of a medicines management informatics system is to improve accountability and case management. Information could be summarized in the form of a set of key indicators. Indicators should be targeted for persons at all levels so that they can monitor both their own performance and that of areas for which they are responsible. At the national and international levels, such a set of indicators for measuring a country's pharmaceutical situation have been proposed (Figure 4) . 20, 21, 22 Figure 5 presents an organizing conceptual framework for medicines management informatics systems. It illustrates the presence of multiple health care delivery systems, public, NGO, and private sectors and depicts major components of their medicines information needs. Collection, analysis and use of data are encouraged at every level of the medicines management systems. 
